IGC Pharma Inc. (IGC)
NYSE · Healthcare
IGC Pharma Inc. Operating Income 2011–2025
IGC Pharma Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- IGC Pharma Inc. operating income for the quarter ending March 31, 2026 was -2.5 M, a 73.96% increase year-over-year.
- IGC Pharma Inc. operating income for the twelve months ending March 31, 2026 was -8.7 M, a 3.95% decrease year-over-year.
- IGC Pharma Inc. annual operating income for 2025 was -7.4 M, a 24.00% decrease from 2024.
- IGC Pharma Inc. annual operating income for 2024 was -9.8 M, a 15.32% decrease from 2023.
- IGC Pharma Inc. annual operating income for 2023 was -11.6 M, a 25.00% decrease from 2022.
- IGC Pharma Inc. annual operating income for 2022 was -15.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
IGC Pharma Inc. Operating Income — FAQ
IGC Pharma Inc. (IGC) operating income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is IGC Pharma Inc.'s operating income?
IGC Pharma Inc. (IGC) reported operating income of -$7M for fiscal 2025.
Where can I see IGC's operating income history?
The chart and table above show IGC Pharma Inc.'s operating income by year and by quarter, including the growth rate.